QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=DE304EC9CDF11B7124964268841F1366;jsessionid=C57F5F3FC8F419FF7AD96B2ECA778D7B;jsessionid=1CD42FDDA7670CDFD2CDAAFFECE28BC4;jsessionid=E844409F909738CC2E41ED859183476B;jsessionid=0330B3DC0C0EE579C7487F90F109ACF2;jsessionid=95C0D9A12C3F2785F591AF3697C3117B;jsessionid=B4280F6E68CE5E59228D6FA7BED59DF0;jsessionid=D528582B43868007C0E66C947349EA3C (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=DE304EC9CDF11B7124964268841F1366;jsessionid=C57F5F3FC8F419FF7AD96B2ECA778D7B;jsessionid=1CD42FDDA7670CDFD2CDAAFFECE28BC4;jsessionid=E844409F909738CC2E41ED859183476B;jsessionid=0330B3DC0C0EE579C7487F90F109ACF2;jsessionid=95C0D9A12C3F2785F591AF3697C3117B;jsessionid=B4280F6E68CE5E59228D6FA7BED59DF0;jsessionid=D528582B43868007C0E66C947349EA3C